Explore evidence

4.2 %In group II of patients with unknown HIV status in Bangui, Central African Republic, HCV infection was diagnosed in 3 out of 71 (4.2%) patients.

Centrafriquehépatite Cpublished 2018Journal of medical virologyPubMeddocument of 7 observations

4.3 %In group I of patients already followed for HIV in Bangui, Central African Republic, HCV positivity was 4.3%.

Centrafriquehépatite Cpublished 2018Journal of medical virologyPubMeddocument of 7 observations

7.1 %In group II of patients with unknown HIV status in Bangui, Central African Republic, HIV infection was diagnosed in 5 out of 71 (7.1%) patients.

CentrafriqueVIH/sidapublished 2018Journal of medical virologyPubMeddocument of 7 observations

52 %Multiple HR-HPV infection was present in 52.0% of those with anal HPV infection.

Centrafriquemultiple HR-HPV infectionpublished 2018PloS onePubMeddocument of 9 observations

82.7 %The prevalence of high-risk HPV (HR-HPV) was 82.7% among those with anal HPV infection in the study population.

Centrafriquehigh-risk HPVpublished 2018PloS onePubMeddocument of 9 observations

41.4 %Multiple HR-HPV infection was more frequent in HIV-positive MSM (41.4%) than in HIV-negative MSM (7.7%).

Centrafriquemultiple HR-HPV infectionpublished 2018PloS onePubMeddocument of 9 observations

40.8 %Nearly half of the children (40.8% at baseline and 48.2% at follow-up) harbored discordant immunovirological responses with a paradoxically high CD4 T-cell count and HIV-1 RNA load.

CentrafriqueVIH/sidapublished 2020MedicinePubMeddocument of 8 observations

23.9 %In group II of patients with unknown HIV status in Bangui, Central African Republic, HBV infection was diagnosed in 17 out of 71 (23.9%) patients.

Centrafriquehépatite Bpublished 2018Journal of medical virologyPubMeddocument of 7 observations

13 %Immunological and virologic nonresponses occurred in 13.0% of children.

CentrafriqueVIH/sidapublished 2020MedicinePubMeddocument of 8 observations

68.9 %HPV types included in the Gardasil-9® vaccine were detected in 68.9% of specimens.

CentrafriqueHPV types included in Gardasil-9®published 2018PloS onePubMeddocument of 9 observations

54.2 %The majority (54.2%) of children showed discordant immunovirological responses.

CentrafriqueVIH/sidapublished 2020MedicinePubMeddocument of 8 observations

69.1 %69.1% of the 42 enrolled MSM were HIV-1-positive.

CentrafriqueVIH/sidapublished 2018PloS onePubMeddocument of 9 observations

7.7 %Multiple HR-HPV infection was present in 7.7% of HIV-negative MSM.

Centrafriquemultiple HR-HPV infectionpublished 2018PloS onePubMeddocument of 9 observations

18.7 %In group I of patients already followed for HIV in Bangui, Central African Republic, hepatitis B surface antigen positivity was 18.7% and HCV positivity was 4.3%.

Centrafriquehépatite Bpublished 2018Journal of medical virologyPubMeddocument of 7 observations

30.9 %30.9% of the 42 enrolled MSM were HIV-negative.

CentrafriqueVIH/sidapublished 2018PloS onePubMeddocument of 9 observations

13.4 %33 (13.4%) children showed rapid virological responses to ART with an undetectable viral load.

CentrafriqueVIH/sidapublished 2020MedicinePubMeddocument of 8 observations

11.9 %HSV-2 DNA was detected in 11.9% of anal swabs.

Centrafriqueherpes simplex virus-2published 2018PloS onePubMeddocument of 9 observations

2.9 %In group I of patients already followed for HIV in Bangui, Central African Republic, 6 out of 208 (2.9%) were unexpectedly negative, corresponding to false positives for HIV by the national HIV algorithm.

CentrafriqueVIH/sidapublished 2018Journal of medical virologyPubMeddocument of 7 observations

36.6 %In group II of patients with unknown HIV status in Bangui, Central African Republic, at least one chronic viral disease was diagnosed in 26 out of 71 (36.6%) patients.

Centrafriquechronic viral diseasepublished 2018Journal of medical virologyPubMeddocument of 7 observations

48.2 %Nearly half of the children (48.2% at follow-up) harbored discordant immunovirological responses with a paradoxically high CD4 T-cell count and HIV-1 RNA load.

CentrafriqueVIH/sidapublished 2020MedicinePubMeddocument of 8 observations

69.1 %The prevalence of anal HPV was 69.1% among 42 MSM in Bangui, Central African Republic.

Centrafriqueanal HPVpublished 2018PloS onePubMeddocument of 9 observations